Our people

View all stories

Building trust and advancing inclusion: Our approach to clinical trials in Uganda

In Uganda, where women are disproportionately impacted by HIV, our community-based research prioritizes meeting patients where they are

Macrocyclic peptides

Macrocyclic peptides: a new research frontier

Merck scientists are exploring macrocyclic peptides, a new way to combine the properties of a biologic in a pill.

collage of photos showing employees working outside

We’re ‘seeing green’ and building a more sustainable business

Our award-winning ‘See Green, Be Green’ sustainability initiative exemplifies our company's and employees' commitment to operating responsibly

Merck HIV researchers

Meet two scientists at the forefront of our HIV research

Two esteemed scientists share their motivations and hopes for the future of HIV research

illustration of octopus multitasking

Our researchers incorporate LLMs to accelerate drug discovery and development

What are artificial intelligence (AI) agents? They're intelligent systems combining large language models (LLM), AI models and tools to iteratively plan, execute and optimize tasks

patient and doctor

Building on our understanding of gynecologic cancers

How we’re driving research forward for women with common types of gynecologic cancer

mom and baby smiling at each other

Merck for Mothers: Expanding access to quality maternal care

More than a decade of strategic partnerships, private sector innovation and data-driven impact are helping create a world where no woman has to die while giving life

collage of photos of scientists working in labs

How Merck scientists are driving next-generation cancer research

Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth

How we can strengthen vaccination programs and build vaccine confidence together

How we can strengthen vaccination programs and build vaccine confidence together

Two Merck leaders share how we’re working to help protect communities from vaccine-preventable illnesses

Wonder Angie

‘Wonder Angie’ enlists her ‘super friends’ to fight oral cancer

After receiving an oral squamous cell carcinoma diagnosis, a head and neck cancer survivor finds hope by embracing science, prioritizing mental health and leaning on her work family

colleague collaborating with the team

Inspiring innovation through diversity and inclusion

We recognize the importance of embedding a culture of inclusion and belonging at every level of our company

the wall street journal 2023

The Wall Street Journal names Merck among top 10 best-managed companies 

We’re proud to be recognized for our strong performance and unwavering commitment to patients

PodcastGroupattable

Podcast: Meet the dealmakers 

Merck’s business development and licensing team explain how they identify new opportunities to strengthen our robust R&D pipeline  

Here for Good: Bridging the gap between bedside and bench

Members of Merck’s lung cancer clinical development team say working in the hospital inspired their drive to innovate for patients

Konkourona villagers celebrating opening of health center

In Burkina Faso, a personal mission to make a difference in one community

Merck colleagues found non-profit to provide critical resources for a village in one of the poorest countries in the world

Dr. Greg Lubiniecki

Here for Good: The human element inspiring our cancer research

Learn how one doctor turned his family connection to cancer into a career driven by scientific innovation

a worker in our Wilson NC facility

How Wilson, N.C., plays a critical role in our commitment to supply

Meet the North Carolina-based manufacturing team that’s producing and packaging our investigational oral antiviral COVID-19 medicine